Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank86
3Y CAGR+7.2%
5Y CAGR+9.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+7.2%/yr
vs +30.8%/yr prior
5Y CAGR
+9.2%/yr
Consistent
Acceleration
-23.6pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.10B | +6.6% |
| 2024 | $1.97B | -12.2% |
| 2023 | $2.24B | +31.6% |
| 2022 | $1.71B | -37.4% |
| 2021 | $2.72B | +100.9% |
| 2020 | $1.36B | +39.0% |
| 2019 | $975.40M | +67.5% |
| 2018 | $582.30M | +7.3% |
| 2017 | $542.53M | +34.1% |
| 2016 | $404.44M | - |